The US Centres for Disease Control and Prevention (CDC) has stated that the US has administered 342,212,051 doses of COVID-19 vaccines and distributed 394,949,575 doses as of 6:00 hours, ET on Monday, Reuters news agency reported on Tuesday.
This is an increase over 341,818,968 vaccine doses administered on 25 July 2021 out of 394,948,975 doses delivered.
According to the CDC, 188,729,282 people had received at least one dose, while 163,173,366 people were fully vaccinated as of Monday.
This tally includes two-dose vaccines from US pharmaceutical companies Moderna (Nasdaq:MRNA) and Pfizer (NYSE:PFE)/BioNTech (Nasdaq:BNTX), as well as Johnson & Johnson's (NYSE:JNJ) one-shot vaccine.
Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic
Sanofi completes acquisition of Vicebio to expand respiratory vaccines portfolio
Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15
Lunai Bioworks receives first LOI to license next-generation immune cell therapy
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses